BA/BE studies 2025 are essential for global generic drug submissions. As the number of submissions continues to increase, countries are actively enhancing their capabilities to keep pace. India has positioned itself as a preferred destination, supported by its technical expertise, growing infrastructure, and regulatory alignment. BA/BE studies are cornerstones in developing and approving generic medicines, […]